Bellasi, Antonio
Cozzolino, Mario
Malberti, Fabio
Cancarini, Giovanni
Esposito, Ciro
Guastoni, Carlo Maria
Ondei, Patrizia
Pontoriero, Giuseppe
Teatini, Ugo
Vezzoli, Giuseppe
Pasquali, Marzia
Messa, Piergiorgio
Locatelli, Francesco http://orcid.org/0000-0002-7505-261X
Article History
Received: 18 July 2019
Accepted: 27 October 2019
First Online: 18 December 2019
Compliance with ethical standards
:
: Authors were members of an Advisory Board on CKD-MBD supported by Amgen. A.B. reports to have received grants for the participation in scientific meetings from Amgen, Sanofi, Vifor Pharma, and to have received an unrestricted research grant from Amgen. M.C. reports to have received grants for the participation in scientific meetings from Amgen, Shire, Abbvie, Vifor Pharma, Baxter. F.L. reports to have received grants for the participation in scientific meetings from Abbvie, Amgen, Roche, Vifor Pharma. The remaining authors have nothing to report with regard to the present paper.
: This review article does not contain any studies with human participants or animal performed by any of the authors.
: Not applicable.